Skip to main content

UBS Group AG

Position in IDXX — Idexx Laboratories Inc /De

CIK 1610520 ZURICH, V8

Position in IDXX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$171,470,284
-$21,308,291 QoQ
Shares Held
305,167
+7.1% QoQ
Ownership
0.387%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 79.11373117014618.ToString("F0")% Shared 0.ToString("F0")% None 20.88626882985382.ToString("F0")%

Common Shares in IDXX Over Time

Shares Held

Position Value (USD)

Derivatives in IDXX

reported options exposure · as of Mar 31, 2024
CallValue
$0
CallShares
0
PutValue
$29,210,213
PutShares
54,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,686,317,391 across 46 Diagnostics & Research names. IDXX ranks #4 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 IDXX
Idexx Laboratories Inc /De
This page
305,167 $171,470,284

All Filings in IDXX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $171,470,284 305,167
2025-12-31 $192,778,575 284,952
2025-09-30 $224,182,026 350,893
2025-06-30 $200,060,716 373,011
2025-03-31 $158,129,229 376,543
2024-12-31 $137,297,220 332,085
2024-09-30 $115,784,800 229,177
2024-06-30 $108,043,905 221,765
2024-03-31 $111,674,260 206,831
2024-03-31 $29,210,213 54,100
2023-12-31 $116,248,559 209,438
2023-09-30 $80,470,359 184,029
2023-06-30 $70,456,339 140,287
2023-03-31 $60,330,150 120,641
2022-12-31 $49,278,302 120,792
2022-09-30 $20,003,791 61,399
2022-06-30 $37,627,364 107,283
2022-03-31 $69,126,499 126,360
2021-12-31 $124,902,616 189,689
2021-09-30 $127,982,666 205,793
2021-06-30 $101,061,261 160,021
2021-03-31 $78,865,517 161,177
2020-12-31 $70,679,117 141,395
2020-09-30 $47,577,709 121,029
2020-06-30 $42,135,348 127,621
2020-03-31 $29,604,392 122,211